These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 7747966)
1. The lysostaphin endopeptidase resistance gene (epr) specifies modification of peptidoglycan cross bridges in Staphylococcus simulans and Staphylococcus aureus. DeHart HP; Heath HE; Heath LS; LeBlanc PA; Sloan GL Appl Environ Microbiol; 1995 Apr; 61(4):1475-9. PubMed ID: 7747966 [TBL] [Abstract][Full Text] [Related]
2. epr, which encodes glycylglycine endopeptidase resistance, is homologous to femAB and affects serine content of peptidoglycan cross bridges in Staphylococcus capitis and Staphylococcus aureus. Sugai M; Fujiwara T; Ohta K; Komatsuzawa H; Ohara M; Suginaka H J Bacteriol; 1997 Jul; 179(13):4311-8. PubMed ID: 9209049 [TBL] [Abstract][Full Text] [Related]
3. Cross-linked peptidoglycan mediates lysostaphin binding to the cell wall envelope of Staphylococcus aureus. Gründling A; Schneewind O J Bacteriol; 2006 Apr; 188(7):2463-72. PubMed ID: 16547033 [TBL] [Abstract][Full Text] [Related]
4. Studies on prolysostaphin processing and characterization of the lysostaphin immunity factor (Lif) of Staphylococcus simulans biovar staphylolyticus. Thumm G; Götz F Mol Microbiol; 1997 Mar; 23(6):1251-65. PubMed ID: 9106216 [TBL] [Abstract][Full Text] [Related]
11. Identification and molecular characterization of a gene homologous to epr (endopeptidase resistance gene) in Staphylococcus aureus. Sugai M; Fujiwara T; Komatsuzawa H; SuginakaH Gene; 1998 Dec; 224(1-2):67-75. PubMed ID: 9931440 [TBL] [Abstract][Full Text] [Related]
12. Mechanism and suppression of lysostaphin resistance in oxacillin-resistant Staphylococcus aureus. Climo MW; Ehlert K; Archer GL Antimicrob Agents Chemother; 2001 May; 45(5):1431-7. PubMed ID: 11302806 [TBL] [Abstract][Full Text] [Related]
13. Internally quenched peptides for the study of lysostaphin: An antimicrobial protease that kills Staphylococcus aureus. Warfield R; Bardelang P; Saunders H; Chan WC; Penfold C; James R; Thomas NR Org Biomol Chem; 2006 Oct; 4(19):3626-38. PubMed ID: 16990938 [TBL] [Abstract][Full Text] [Related]
14. Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus. Strandén AM; Ehlert K; Labischinski H; Berger-Bächi B J Bacteriol; 1997 Jan; 179(1):9-16. PubMed ID: 8981974 [TBL] [Abstract][Full Text] [Related]
15. Cloning and expression of Far BE; Ragheb M; Rahbar R; Mafakher L; Nojookambari NY; Achinas S; Yazdansetad S AIMS Microbiol; 2021; 7(3):271-283. PubMed ID: 34708172 [TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of the antibacterial peptidase lysostaphin from Staphylococcus simulans: Adverse influence of Zn Chandra Ojha S; Imtong C; Meetum K; Sakdee S; Katzenmeier G; Angsuthanasombat C Protein Expr Purif; 2018 Nov; 151():106-112. PubMed ID: 29944958 [TBL] [Abstract][Full Text] [Related]